PATENT CLAIM ANALYSIS

Application Number: 16177602
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["544", "280000"]

Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

Claim (Index 90):
The method of  claim 89 , wherein said compound or salt is administered in the form of a pharmaceutical composition suitable for skin administration, comprising said compound or salt and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.5641
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15356957', '13076176', '13076220', '14274948', '15233652']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7341194309275926
- 35 USC 102 Novelty (BERT): 0.5672471972036481
- Combined Prediction Score: 0.7174322075551982
- Mean Citation Score: 480.478192
- Max Citation Score: 492.96155
- Similarity Product: 341.44597838058473

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test